CT-P39

· Celltrion

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CT-P39, covering 2023-05-11 to 2025-07-29. Get the full timeline:

Most recent: Clinical Trial Update: To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria [Phase 3]

See pricing